Entag, Erwin D.
HRN: 24-16-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/04/2023
12/12/2023
IV
500mg
TID
H Pylori With Acute Gastroenteritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes